Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.2.4ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-1981.59Japan
JN.1.1.10ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-1981.59Japan
JN.4ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-1981.59Japan
BA.2.86ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-1981.59Japan
GK.2ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-1981.59Japan
HN.5ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-1981.59Japan
XCRORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-1981.59Japan
GW.5.3ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-1981.59Japan
HN.6ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-1988.81Singapore
FL.25ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-1988.81Singapore
GN.4ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-1988.81Singapore
B.1.595.3ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-1988.81Singapore
B.1.2ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-1988.81Singapore
GA.4.1ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-1988.81Singapore
BQ.1.1.70ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-1988.81Singapore
BC.1ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-1988.81Singapore
B.1.1.53ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-1988.81Singapore
BA.2.75.1ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-1988.81Singapore
FF.1ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-1988.81Singapore
XBB.1.5.90ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
FT.3ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
JN.1.4.1ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
BQ.1.1.10ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
BQ.1.1.56ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
JN.1.18.7ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
XBB.1.9ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
XBB.1.16.7ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
GW.4ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
HY.1ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
HC.4ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
HW.1ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
GS.3ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
HK.12ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
BA.2.86.2ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
DV.7.1.2ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
XDEORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
KH.1ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
XDD.1ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
XBVORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
BA.2.3.2ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
BA.2.3.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
XDNENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
BN.1.3.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
XDK.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
JN.1.4.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
FL.32.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
GA.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
GE.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
MD.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
KR.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used